Spark Biomedical News

Spark Biomedical Deepens Behavioral Health & Neurostimulation Expertise with Two Key HiresRead More
Bux Pain Management Treats First Commercial Patient in the Nation Using Spark Biomedical’s Sparrow Therapy SystemRead More
Spark Biomedical’s Sparrow Therapy System™ receives FDA Clearance for Opioid Withdrawal Relief in AdultsRead More
Spark Biomedical Receives FDA Breakthrough Device Designation for Infant Transcutaneous Auricular Neurostimulation (tAN™) Device, The Roo™ SystemRead More
Transcutaneous Auricular Neurostimulation (tAN™) for Opioid Withdrawal Selected as a Top Abstract by American Society of Pain and NeuroscienceRead More
Nine of the Foremost Pain Management Physicians Join the Spark Biomedical, Inc. Medical Advisory BoardRead More
Neurostimulation Clinical Trial Shows Promising Initial Results in Easing Opioid Withdrawal Symptoms in NewbornsRead More
Spark Biomedical takes “Best in Show” at 2020 NANSRead More
Spark Biomedical Presents and Exhibits at the North American Neuromodulation Society 23rd Annual ConferenceRead More
Spark Biomedical Launches Clinical Trial to Treat Opioid WithdrawalRead More